Study: 46.7 million Americans have Alzheimer’s Disease brain pathology today, so it’s urgent to prevent or at least delay progression to clinical disease

New fore­cast shows 6 mil­lion with Alzheimer’s dis­ease, cog­ni­tive impair­ment; The num­bers will more than dou­ble to 15 mil­lion by 2060 (NIH news): “Using new method­ol­o­gy, sci­en­tists cal­cu­late that approx­i­mate­ly 6 mil­lion Amer­i­can adults have Alzheimer’s dis­ease or mild cog­ni­tive impair­ment, which can some­times be a pre­cur­sor to the dis­ease. The esti­mate, fund­ed by the National…

Read More

Ever heard of the Longevity Dividend? Perhaps Gray is the New Gold

The Longevi­ty Div­i­dend is a the­o­ry that says we hope to inter­vene sci­en­tif­i­cal­ly to slow the aging process, which will also delay the onset of age-relat­ed dis­eases. Delay­ing aging just sev­en years would slash rates of con­di­tions like can­cer, dia­betes, Alzheimer’s dis­ease and heart dis­ease in half. That’s the longevi­ty part. The div­i­dend comes from the…

Read More

Making Healthy Choices: Primare Care and Prevention

Hiroshi Komiya­ma, Pres­i­dent of the Uni­ver­si­ty of Tokyo and Chair­per­son of the Glob­al Agen­da Coun­cil on the Chal­lenges of Geron­tol­ogy I am a mem­ber of, just pro­vid­ed coun­cil mem­bers with a brief update of his par­tic­i­pa­tion in the recent World Eco­nom­ic Forum. Part of the pro­ceed­ings are pub­lic — you may enjoy read­ing this pan­el write-up…

Read More

Neurotechnology Trends, and the Neurosoftware Market

The Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion (NIO) just announced the top ten emerg­ing areas of neu­ro­science that will “impact the future of treat­ments for brain and ner­vous sys­tem”: Top 10 Neu­ro­science Trends in 2007. It pro­vides superb food for thought. And some of them will sound famil­iar to read­ers of this blog: * 6. Nor­mal brain aging gets…

Read More